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Effects of cyclosporine A on Na,K-ATPase expression in the renal
epithelial cell line NBL-1. The bovine renal epithelial cell line NBL-1 has
been used to monitor the effects of cyclosporine A (CsA) on Na,Kt
ATPase activity and expression. CsA at two single doses (0.6 mg/liter and
2.5 mg/liter) inhibits the ouabain-sensitive component of Rb uptake,
assumed to be Na,KtATPase, but increases the low activity of a
furosemide-sensitive component corresponding to a Na*IK*ICI_ cotrans-
porter. CsA addition also induces a slight decrease of ol subunit mRNA
levels, without altering the already low 131 subunit mRNA amounts.
Hypertonic treatment of NBL-1 cells leads to a significant increase in both
Na,K-ATPase activity and ul subunit mRNA amounts, but does not
modify 131 subunit mRNA levels. The differential response of the ol and
/31 subunit genes may explain why hypertonic treatment does not result in
higher al protein expression, and supports the view that increased activity
relies upon post-translational events, despite the likely transcriptional
activation of the al subunit gene. The addition of CsA does not alter the
hypertonicity-mediated increase of Na,KtATPase activity but blocks
the accumulation of csl subunit mRNA. In conclusion, CsA may compro-
mise the ion handling by renal cells as a result of the inhibition of basal
Na,K-ATPase activity and the stimulation of Na/K7CL cotransport
activity. Morevoer, this is the first report showing that CsA may affect the
long-term adaptation of the pump by altering its subunit gene expression.
yclosporine A (CsA) is a lipophylic polypeptide that bears
unique properties as an immunosupressant, thus being widely
used in the prevention of graft rejection after organ transplanta-
tion [1]. Nevertheless, CsA administration promotes collateral
cytotoxic effects challenging normal kidney function, The admin-
istration of CsA rapidly induces a reduction in both renal plasma
flow (RPF) and glomerular filtration rate (GFR) and blocks the
natural increase in GFR induced by a protein load, mimicked
experimentally by an amino acid infusion [2-4]. Longer-term
effects of the drug involve a reduction of the nucleic acid content
of kidney cortex, which is consistent with the idea that CsA may
impair tissue hypertrophia and hyperplasia [4]. The possibility that
CsA induces cell toxicity by altering the normal activity of key
plasma membrane transport proteins has been suggested previ-
ously and, indeed, the drug has been shown to interact directly
with the Na-D-glucose cotransporter [51 and inhibit renal
Na,K-ATPase activity either when administered in vivo [61 or
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in vitro [71 The inhibition of Na,K-ATPase activity by CsA has
also been involved in the development of hyperkalemia [71. CsA,
due to its physico-chemical properties, is also able to interact with
a variety of other proteins that play key roles in cell physiology,
such as cytoskeletal elements or some components of the steroid-
receptor protein complexes [8].
Inhibition of Na,K-ATPase by CsA may be of pathophysio-
logical relevance due to the essential role of the sodium pump in
ion homeostasis and organic solute uptake. Nevertheless, the
exact molecular mechanisms involved in this effect are not well
understood. CsA action seems to be nephron segment specific [71
and its time course may vary depending on the experimental
model chosen [6, 7]. Using isolated segments, CsA exerts a
maximum inhibition of about 40% in only 30 minutes, a lag time
that is consistent with short-term modulation of the pump not
requiring, in principle, any effect at the gene level. Nevertheless,
the possibility of this second kind of CsA action has not been
studied so far. This study addresses the question of whether the
drug may modulate the expression of the sodium pump by
monitoring the effects of the CsA on the basal and the hyperto-
nicity-mediated increased mRNA levels of the Na,K-ATPase
subunits. To monitor CsA action we have used the bovine renal
epithelial cell line NBL-1, which has been extensively character-
ized in terms of carrier expression and modulation [9—16]. NBL-1
cell line was a good candidate for such a study, since it expresses
transport activities (such as Nat-dependent phosphate transport
and broad-specificity Natdependent amino acid transport) that
are also expressed in the intact bovine kidney cortex, where the
cell line was derived. These cells also retain some of the Na,K-
ATPase regulatory trends described in kidney cells, such as the
transcriptional regulation of the al subunit expression under
hypertonic shock [17], also observed in human renal tubule cells
[18]. Thus, NBL-1 cells may be a suitable tool to study the
potential effects of CsA on renal plasma membrane carrier
expression and function.
Methods
Cell line and culture
NBL-1 cells were obtained from Flow Laboratories (McLean,
VA, USA). Cells were routinely grown in Ham's F-12 medium
supplemented with 10% (vol/vol) newborn calf serum, 2 mi
glutamine and antibiotics as described previously [9, 10]. Prior to
any treatment, cells were cultured for 24 hours in a serum-free
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medium suplemented with 0.1% (wt/vol) bovine serum albumin
(BSA). This is based upon previous evidence showing that in other
cell types, like the rat liver cell line clone 9, serum itself promotes
the activity of the pump and the expression of its subunits [19].
For hypertonicity experiments, confluent monolayers were cul-
tured for 24 hours in the serum-free medium containing 200 mrvi
sucrose, a culture condition known to exert maximal stimulation
of system A and XAG activities in NBL-1 cells [12, 161. Confluent
monolayers were incubated in the presence of CsA (Sandoz,
Basel, Switzerland), at a concentration of either 0.6 mg/liter or 2.5
mg/liter for different time periods depending on the specific goal
of every experiment.
DNA synthesis in NBL- 1 cells
To monitor the DNA synthesis of NBL-l cells and the potential
effects of CsA on this parameter, we measured the incorporation
of radiolabeled thymidine into DNA. After growing the cells in
normal conditions, they were cultured in serum-free medium for
24 hours and then incubated in fresh complete medium again for
16 or 24 hours either in the presence or in the absence of 2.5
mg/liter CsA. Three hours before the incubation time had
elapsed, 4 1iCi of tritiated thymidine were added to the plates. At
the end of the experiment, cells were washed twice with PBS for
five minutes and incubated for 30 minutes at 4°C with I ml of 5%
TCA supplemented with 1% sodium pyrophosphate. After two
washings with 5% TCA at 4°C for three minutes and a last
washing with cold PBS, ethanol was added before drying the
plates. Cell extracts were resuspended by incubating them in 0.6
ml 0.3 si NaOH for one hour at 4°C. Aliquots were neutralized
with HCI and used for radioactivity counting. Protein determina-
tion of the cell extracts was run in parallel using the method
described in [20]. Results were expressed as dpm incorporated
into DNA during the three hours incubation period per mg of cell
protein.
Transport measurements
To evaluate the biological activity of the Na ,K-ATPase in
intact cells, we monitored Rb uptake either in the presence or in
the absence of 1.2 mrvt ouabain. The method used was adapted
from the one described in [21], which has the advantage of using
non-radioactive Rb. Confluent monolayers were washed once
with 1 ml of Tris (hydroxymethil) aminomethane (Tris 26 ms, pH
7.4)-buffered Earle's balanced salt solution (EBSS) containing 116
mM NaCI, 5.4 mtvi KCI, 1.8 mvt CaCI2, 1 mvt NaH2P04, 0.8 mM
MgSO4, 5.5 mrvi D-glucose, which was supplemented with 1%
(wt/vol) BSA. Cells were incubated in I ml of the same fresh
medium for 30 minutes. Then the medium was rapidly replaced by
1 ml of the incubation medium (the same described above but
supplemented with 5.4 m'vi RbCI instead of KCI). The reaction
was stopped after five minutes incubation by aspirating the
medium, followed by two washings with 2.5 ml of an ice-cold 0.1
M MgCl1 solution. Cells were dried, 0.2 ml of absolute ethanol
added and let evaporate. Plates were routinely frozen until Rh
contents were measured by atomic absorption spectrophotometty
(Philips PU9200X) using a wavelength of 780 nm with a slit of 1 nm.
The ouabain-insensitive fraction of Rb + uptake was shown to
be furoscmide sensitive when cells were preincubated in the
presence of 1.2 mi furosemide prior to Rb transport measure-
ments.
The protein content of the cell extracts was measured following
Fig. 1. Components of Rh uptake in NBL-1 cells. Confluent monolayers
of NBL-1 cells were used for Rb- uptake measurements, as indicated in
the text, after a 24 hours incubation either in basal conditions (isotonic
medium; •) or in the presence of 200 m sucrose (hypertonic medium;). Rb transport determinations were performed either in the absence(total uptake) or in the presence of 1.2 mM ouabain (+0) or 1.2 mM
furosemide (+F). The results are the mean SEM of triplicate estimations
made on seven independent cell preparations. The t-test was used to assess
the statistical significance of the differences between control and sucrose
treated cells (°°P < 0.01).
the method referenced above [20] and the results expressed as
nmol Rbt'5 mm/mg cell protein.
Na -A TPase al subunit protein
Western blot analysis of al subunit protein amounts was
performed using a al specific polyclonal antibody provided by Dr.
Käthi Geering (Institute of Pharmacology, University of Lau-
sanne, Switzerland). Confluent cell monolayers were cultured
under the conditions indicated above. Plates were washed once
with 1 ml of 10 mvt Tris (pH 7.4), then scraped in I ml of the same
medium and whole extracts added to 9 ml of the same buffer.
Extracts were centrifuged for 10 minutes at 10,000 g. Pellets were
washed once in 10 ml of 10 mrvi Tris, centrifuged again and cell
extracts to be used for eletrophoresis resuspended in 0.2 ml of
0.5% Triton-X100. The crude membrane preparations were used
also for protein determination [20]. Eight micrograms of protein,
supplemented with /3-mercaptoethanol (5% final concentration),
were routinely run on a 0.1% SDS-polyacrylamide gel. Proteins
were transferred into filters (Immobilon-P; Millipore, Bedford,
MA, USA), blocked in 5% milk, 0.2% Tween-20 PBS and
immediately used for immunoreaction. The amounts of 131 sub-
unit protein could not be measured using the available antibodies.
Na ,K-ATPase subunit mRNAs
Total RNA was extracted from confluent cell monolayers using
the single step method [22]. RNA was then separated on a 1%
agarose gel under denaturing conditions, transferred overnight to
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Fig. 2. Effect of CsA on 3H-thymidine incolporation into DNA in IVBL-1
cells. NBL-1 cells were synchronized by culturing them for 24 hours in the
absence of serum (Methods section). Thereafter, incorporation of radio-
labeled thymidine into DNA was measured by growing the cells for 16
more hours either in the absence (a) or in the presence of serum (b). The
effect of 2.5 mg/liter CsA on thymidine incoporation in NBL-1 cells
cultured in the presence of serum either for 16 hours (c) or 24 hours (d)
was determined. A high dose of the drug (25 mg/liter) was also used for 24
hours in a last set of experiments (e). The results are the mean SCM of
triplicate estimations made on three independent cell preparations. Sta-
tistical significance of the effects induced by CsA was assessed by ANOVA
test (P < 0.0001 for CsA dose and P = 0.0028 for time dependence)
followed by Tuckey's protected test (°°P < 0.01; *** < 0.001).
nylon membranes (Hybond N, Amersham, UK) in 20 X SSC (3 M
NaC1, 300 m sodium citrate, pH 7.0) and cross linked under UV
exposure. Blots were prehybridized for six hours at 42°C in 45%
formamide, 10% dextran sulphate, lx Denhart's solution (1
g/liter bovine serum albumin, 1 g/liter polyvinylpyrrolidone 40, 1
g/liter Ficoll), 4 >< SSC, 100 m sodium phosphate buffer (pH 7),
0.1% sodium pyrophosphate, 0.1 mg/mi sonicated salmon sperm
DNA and 0.1% dodecyl sulphate (SDS). Blots were routinely
hybridized for 24 hours at 42°C in the same solution with either
the 32P-Iabeled al subunit or 1 subunit eDNA probes (provided
by Dr. Robert Levenson, Yale University School of Medicine,
New Haven, CT, USA). Spots were quantified by means of
Biolmage software (Millipore Corporation) and normalized to
the ethidium bromide staining of the ribosomal bands, which were
also quantified using the same system. To further demonstrate
that the observed differences were not due to loading artifacts, we
used as a control the amounts of mRNA of the L32 ribosomal
protein, as previously described [231.
Results
Components of Rb uptake in NBL-1 cells
The characteristics of Rh uptake into NBL-1 cells when grown
in either a isotonic or a hypertonic medium are shown in Figure 1.
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Fig. 3. Time-course of the effect of GsA on ouabain- and furosernide-
sensitive Rb uptake in NBL-1 cells. Confluent monolayers of NBL-1 cells
were cultured for the indicated times either in the absence (closed
symbols) or in the presence (open symbols) of 2.5 mg/liter GsA. Ouahain-
sensitive (circles) and furosemide-sensitive (squares) Rh- uptake rates
were monitored as indicated in the text. Results are the mean SCM of
triplicate estimations made on four independent cell preparations. The
ANOVA test indicates a P < 0.001 for the GsA treatment on the
ouahain-sensitive component and a P < 0.01 on the furosemide-sensitive
uptake. Significance of the subsequent Tuckey's protected test is °P <
0.05.
In isotonic conditions, most of the Rb transport occurs through
an ouabain-sensitive pathway, which may correspond essentially
to Na',K'-ATPase activity. After hypertonic treatment, the
activity of the sodium pump increases and a furosemide-sensitive
component of Rb uptake is dramatically up-regulated. This is
likely to correspond to the activation of the Na' /K'/CL cotrans-
porter.
Effect of GsA on 3H-thymidine incorporation into DNA in
NBL- I cells
The effect of 2.5 mg/liter CsA on 3H-thymidine incorporation
into the DNA of NBL-1 cells is shown in Figure 2. Sixteen hours
of CsA treatment (2.5 mg/liter) resulted in a maximal reduction of
thymidine labeling of nearly 50% when compared to the cells that
were not incubated with the drug. Similar values were obtained
when cells were incubated with the drug for longer periods of time
(24 hr). These experiments were performed in the presence of
serum, conversely to the study of Na,K' -ATPase activity and
expression where serum had been replaced by BSA as explained
above. Nevertheless, we showed that the incubation of NBL-1
cells for 16 hours in the absence of serum did not modify the
incorporation of thymidine into DNA, when compared to cells
cultured in complete medium (Fig. 2). This may not be the case
when using other renal cell lines, because when we checked this
parameter in the cpithelial OK cell line derived from the OOSSUfl1
kidney, the incubation of the cells in the absence of serum
decreased thymidine incorporation to a 30% of the basal values
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Fig. 4. Effect of CsA concentration on ouabain- and furosemide-sensitive
Rb uptake in NBL-1 cells. The effect of two concentrations of CsA, 0.6
mg/liter () and 2.5 mg/liter (Li) on the two components of Rb uptake
in NBL-1 cells, oubain-sensitive (Na,K LATPase) and furosemide-sen-
sitive (Na/K7Cl cotransporter), was monitored, after incubating the
cells for 24 hours either in the absence or in the presence of the drug.
Control values are depicted by (s). Results are the mean SEM of
triplicate estimations made on three independent cell preparations. Dif-
ferences induced by CsA were assessed by ANOVA test (P = 0.0007 for
ATPase and P 0.0352 for Na/K7Cl cotransporter activities, respec-
tively). Significances of the subsequent Tuckey's protected test are *p <
0.05 and 'P < 0.01.
(not shown). However, when added to OK cells, 2.5 mg/liter CsA
also exerted an inhibitory action on thymidine labeling of cell
DNA of a magnitude similar to the one reported in NBL-1 cells
(not shown).
Effect of CsA addition on the ouabain- and furosemide-sensitive
components of Rb uptake in isotonic medium
The time course of the effects induced by 2.5 mg/liter CsA on
both components of Rb uptake (ouabain- and furosemide-
sensitive) is shown in Figure 3. CsA significantly inhibited the
activity of the sodium pump but stimulated that of the Na1K+/
Cl - cotransporter. The effect was already evident at the first time
point studied (6 hr). Although in isotonic conditions the basal
activity of the cotransporter was much lower than that of the
Na F
,K-ATPase, in relative terms the stimulatory effect triggered
by the drug on the Na '7K/CL cotransporter was much higher
than the inhibitory effect exerted on the sodium pump. As shown
in Figure 4, the effect induced by CsA on both transport systems
was evident even when lower doses of the drug were used (0.6
mg/liter).
Fig. 5. Effect of hypertonicily and CsA on oubain- and flirosemide-sensitive
Rb uptake in NBL-1 cells. Confluent monolayers of NBL-1 cells were
incubated for 24 hours in a medium suplemented with either (i) 2.5
mg/liter of CsA (), (ii) 200 m sucrose (), or (iii) 200 m sucrose and
2.5 mg/liter of CsA (LI). Then, the ouabain- and furosemide-sensitive
components of Rb uptake were monitored, as indicated in the text. Solid
bars (•) depict control values. Results are the mean SEM of triplicate
estimations made on three independent cell preparations. Statistical
significance of the differences was assessed using the paired t-test (*P <
0.05; < 0.01).
Effect of CsA on the response to hypertonic shock of the
Na ,K-ATPase and the Na /K7C1 cotransporter
As indicated above, hypertonic treatment of the cells enhances
Na,K -ATPase and Na/K /C1 cotransporter activities to a
different extent. Figure 5 shows that CsA, even when used at high
doses (2.5 mg/liter), is not able to block the adaptive response of
these transport systems to hypertonicity. Interestingly, the in-
crease in activity of the sodium pump does not correlate with
significant changes in the amount of al subunit protein (Fig. 6).
As we have previously shown [17], this can be explained by the fact
that this enhancement was probably due to post-translational
events and not related to an increase in the number of pumps,
because the difference in activity between both experimental
conditions, isotonicity and hypertonicity, can be completely abol-
ished when the activity of the Na,K-ATPase was measured in
the presence of monensin, a Na ionophore [17]. CsA did not
modify the amount of al subunit protein either in isotonic or in
hypertonic conditions.
Ejfrct of C'sA on a] subunit Na ,K-A TPase mRNA
Hypertonic treatment of NBL-1 cells induces a threefold in-
crease in the mRNA amounts for the csl subunit of the Na,K -
ATPase, which is clearly significant six hours after the addition of
the osmolyte (Fig. 7). In this ccli line, hyperosmotic shock does
not induce any change in the basal low amounts of the mRNA for
the /31 subunit of the pump. The addition of 2.5 mg/liter CsA
induced a slight and progressive decay of the al subunit mRNA
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Fig. 6. Lack of ejft?ct of csA on cr/ subunit protein levels in NBL-1 cells. NBL-l cells were monitored for Na,K-ATPase cr1 subunit protein amounts
by Western blot analysis. A. The mean SCM of the densitometric analysis of three independent preparations. Results are expressed as arbitrary units
assuming that in basal conditions (isotonic medium without CsA) the value at the indicated incubation times is 1 (dotted line). Symbols arc: (•) isotonic
medium + 2.5 mg/liter CsA; () hypertonic medium; (LII) hypertonic medium + 2.5 mg/literCsA. B. A representative Western blot. Abbreviations are:
B, basal conditions (isotonic); CsA, 2.5 mg/liter CsA in isotonic conditions for 24 hours; H, hypertonic conditions for 24 hours; H+CsA, 2.5 mg/liter
CsA in hypertonic conditions for 24 hours.
amounts when cells were cultured in an isotonic medium. Never-
theless, the most impressive effect of the drug was the blocking of
the cr1 subunit mRNA accumulation that occurred when cells
were treated with sucrose. CsA almost, but not fully, blocked this
increase in mRNA levels.
Discussion
CsA addition to NBL-i cells induces similar effects to those
described in other cell models, such as inhibition of thymidine
incorporation into DNA and slight but significant decrease in the
activity of Na,K-ATPase [24, 25]. This effect is not attributable
to changes in the number of sodium pumps, because the amount
of cr1 subunit protein was not affected by the drug. This study also
shows that CsA enhances the activity of the Na7KICL cotrans-
porter in NBL-1 cells.
The osmotic response of Na,K-ATPase in NBL-l cells is
particularly interesting. Essentially the activity increases by a
mechanism that appears to be post-translational. This may be a
common phenomenon for the renal sodium pump because it
appears to be regulated in a complex way by a variety of stimuli
involving protein kinases A and C [26]. This is based upon the
evidence that, although the cr1 subunit mRNA amounts increase
after hypertonic shock, l subunit mRNA levels are not affected
after hypertonic treatment, which probably limits the synthesis of
pumps and explains the unaltered levels of cr1 subunit proteins. It
is recognized that there is a mutual dependence of both subunits
for correct post-translational processing and intracellular trans-
port of the mature sodium pumps [27]. Therefore, a lack of
coordination in the expression of both genes may not increase the
number of pumps despite the transcriptional activation of a single
gene. There are other examples of this kind regarding the
regulation of Na,K-ATPase in other cell types [28—30]. In
CHO-KI cells, cr1 subunit gene expression is regulated by amino
acid availability withouth altering Na,K' -ATPase activity [28].
In other cell lines, like in clone 9 cells, a twofold increase above
basal levels of the mRNA amounts for the cr1 subunit does not
result in significant increases in Na,K-ATPase activity, despite
a simultaneous enhancement of 1 subunit mRNA that reaches
40-fold above basal levels [30, 31]. Further evidence supporting
the view that the induction of the pump activity after hypertonic
shock is basically post-transcriptional in origin comes from the
finding that CsA is not able to modify the hypertonicity-induced
activity of the pump, but almost completely blocks the mRNA
accumulation of the cr1 subunit mRNA levels after hypertonic
treatment. The reason why CsA can inhibit basal but not hyper-
tonically-stimulated Na,K-ATPase activity in NBL-1 cells is not
clear, but may rely on the biochemical mechanisms responsible for
the induced activity, which seem to involve the Na transmem-
brane gradient, as the effect triggered by medium tonicity disap-
pears when cells are incubated in the presence of a Na iono-
phore [171. Insummary, CsA may alter the activity of the pump by
short-term mechanisms, as the ones also reported in human
erythrocytes [321. Although no evidence has been provided so far
showing that the Na,K-ATPase is a CsA-binding protein, the
findings that CsA binds actin and that the pump may be linked to
a variety of cytoskeletal elements that modulate its own activity [8,
33—35] opens the possibility that both polypeptides indirectly
interact by means of the cytoskeleton.
This study also provides the first evidence that CsA, when
added in vitro to renal epithelial cells, is able to block Na ,K -
ATPase at subunit gene expression, especially when the cells are
incubated in conditions known to exert an increase in cr1 subunit
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Fig. 7. Effect of GsA on basal and hypertonicity-increase a] subunit mRNA levels in NBL-1 cells. A. Confluent monolayers of NBL- I cells were cultured,
for the indicated times, either in isotonic conditions (•) or in the presence of 200 m sucrose (0, •), either in the presence (solid symbols) or in the
absence (open symbols) of 2.5 mg/liter CsA. The results are the mean SCM of the densitometric analysis of four independent cell preparations,
assuming that the value 1 corresponds to the amounts of al subunit mRNA when cells were cultured in isotonic conditions and in the absence of the
drug. B. A representative Northern blot result of cells that had been incubated for nine hours either in isotonic conditions, without 2.5 mg/liter CsA
(B) and with CsA (CsA), or in hypertonic conditions without (H) and with 2.5 mg/liter CsA (H+CsA). C. Ethidium bromide staining of the ribosomal
bands in the gel. D. L32 ribosomal protein hybridization.
mRNA levels. Hypertonicity up-regulates the al subunit gene
because it promotes the accumulation of its mRNA [17, 25] and it
is not accompanied by significant changes in mRNA stability [171.
Thus, the Na,KtATPase cxl subunit gene is an osmotically
sensitive gene and the target of CsA action. It is likely that this
effect is specific because the basal mRNA amounts are poorly
affected by the drug, and the j31 subunit mRNA levels, which are
not up-regulated after hypertonic shock, are not affected by the
addition of CsA. Specific actions of CsA on gene expression have
previously been involved in the mechanism of immunosuppres-
sion. Indeed, it has been shown that the drug is able to inhibit
TNFa production by cultured human proximal tubular cells in a
manner that involves a depletion of TNFa mRNA levels [31].
Regarding the role of CsA on the Na ,K' -ATPase response to
hypertonicity, it is evident that, although the drug inhibits ai
subunit mRNA accumulation, it does not alter the activity of the
pump. Nevertheless, it is likely that the regulation of the sodium
pump by anisotony may rely upon the expression of both subunit
genes in specific tubular segments, thus resulting in de novo
synthesis of pump units [25]. In that case, inhibition of csl subunit
gene expression by CsA, as reported in this study, may impair the
adaptive response of Na,K-ATPase to hypertonic shock. This
hypothesis, however, requires further examinations
Another interesting finding of this study is the evidence that
CsA treatment of NBL-1 cells results in a significant increase of
the furosemide-inhibitable component of Rb uptake, likely to be
due to a Na±/K*/Cl cotransport activity. Although the induction
of Na,K-ATPase triggered by hypertonicity may be related to
the increase in Na±/K*/Cl - cotransport activity, essentially be-
cause of the Na coupling of both transport systems, it does not
seem to be the case for the differential effect of CsA on these
transport activities. It would be tempting to assume that an altered
transmembrane potassium gradient due to the inhibition of the
sodium pump may induce the cotransporter. However, this is not
necessarily true, since an inhibition of the Na,KtATPase would
also cause an increase in the sodium intracellular concentration,
which should decrease the activity of the cotransporter.
In summary, this study shows that ion handling may be com-
promised in renal cells after treatment with CsA, by altering the
activity of key transport systems at the plasma membrane, such as
the Na,K-ATPase and the Na/K/Cl cotransportcr. CsA
also acts at the gene level by diminishing the Na,KtATPase al
subunit mRNA amounts and by blocking the response of the al
subunit gene to hypertonic shock. This finding opens the possibil-
ity that CsA may impair the adaptive response of the sodium
pump in those situations where Na,K-ATPase induction relies
upon an increased transcription of the subunit genes.
3-
1488 Ferrer-Martinez et al: CsA effects on Na,K-ATPase in NBL-l
B
A 8s)'4
18  )
C
s )
18 )
D
1—
0-
Fe,rer-Martinez et al: CsA effects on Na,K-ATPase in NBL-1 1489
Acknowledgments
This work has been supported by grant PB92-0867 from D.G.I.C.Y.T.
(Ministerio de Educación y Ciencia, Spain) and grants 93/0434 and
95/1751 from F.I.S. (Ministerio de Sanidad y Consumo, Spain).
Reprint requests to Dr. Marcal Pastor-Anglada, Departament de Bio-
quimica i Biologia Molecular, Universitat de Barcelona, Diagonal 645, 08028
Barcelona, Spain.
References
1. FAULDS D, GOA KL, BENFIELD P: Cyclosporin. A review of its
pharmacodynamic and pharmacokinetic properties, and therapeutic
use in immunoregulatory disorders. Dmgs 45:953—1040, 1993
2. MURRAY BM, PALLER MS, FERRIS TF: Effect of cyclosporine admin-
istration on renal hemodynamics in conscious rats. Kidney mt 28:767—
774, 1985
3. CAIRNS HS, RAVAL U, NEILD GH: Failure of cyslosporine-treated
renal allograft recipients to increase glomerular filtration rate follow-
ing an amino acid infusion. Transplantation 46:79—82, 1988
4. BATLLE DC, GUTFERMAN C, KEILANI T, PECES R, LAPOINTE M: Effect
of cyclosporin A on renal function and kidney growth in the unine-
phrectomized rat. Kidney mt 37:21—28, 1990
5. ZIEGLER K, FRIMMER M, FRITZSCH G, KOEPSELL H: Cyclosporin
binding to a protein component of the renal Na-D-glucose cotrans-
porter. J Biol Chem 265:3270—3277, 1990
6. SUZUKI 5, OKA T, OHKUMA 5, KURIYAMA K: Biochemical mechanisms
underlying cyclosporin-induced nephrotoxicity: Effect of concomitant
administration of prednisolone. Transplantation 44:363—368, 1987
7. TUMLIN JA, SANDS JM: Nephron segmen-specific inhibition of
Na,KtATPase activity by cyclosporine A. Kidney mt 43:246—251,
1993
8. Moss ML, PALMER RE, KUZMIC P, DUNLAB BE, HENZEL W, KOFRON
JL, MELLON WS, ROYER CA, RICH DH: Identification of actin and
hsp70 as cyclosporin A binding proteins by photoaffinity labeling and
fluorescence displacement assays. J Biol Chem 267:22054—22059, 1992
9. HELPS CR, MCGIVAN JD: Adaptive regulation of Na-dependent
phosphate transport in the bovine renal epithelial cell line NBL-1.
Identification of the phosphate transporter as a 55-kDa glycoprotein.
EurfBiochem 200:797—803, 1991
10. DOYLE FA, MCGI VAN JD: The bovine renal epithelial cell line NBL-1
expresses a broad specificity Nat-dependent neutral amino acid
transport system (System B°) similar to that in bovine renal brush
border membrane vesicles. Biochim Biophys Acta 1104:55—62, 1992
11. FELIPE A, SOLER C, MCGI VAN JD: Amino acid deprivation leads to
the emergence of system A activity and the synthesis of a specific
membrane glycoprotein in the bovine renal epithelial cell line NBL-1.
Biochem J 284:577—582, 1992
12. SOLER C, FELIPE A, CASADO FJ, MCGI VAN JD, PASTOR-ANGLADA M:
Hyperosmolarity leads to an increase in derepressed system A activity
in the renal epithelial cell line NBL-1. Biochem J 289:653—658, 1993
13. PLAKID0U-DYM0CK 5, MCGIVAN JD: Regulation of the glutamate
transporter by amino acid deprivation and associated effects on the
level of EAAC1 mRNA in the renal epithelial cell line NBL-1.
Biochem J 295:749—755, 1993
14. RUIZ-MONTASELL B, GOMEZ-ANGELATS M, CAsno FJ, FELIPE A,
MCGI VAN JD, PASTOR-ANGLADA M: Evidence for a regulatory protein
involved in the increased activity of system A for neutral amino acid
transport in osmotically stressed mammalian cells. Proc NatlAcad Sci
USA 91:9569—9573, 1994
15. PIAKIDOU-DYMOCK 5, TANNER MJA, MCGIVAN JD: Regulation of
system B° amino acid transport activity in the renal epithelial cell line
NBL-1 and concomitant changes in SAAT1 hybridizing transcripts.
Biochem J 301:399—405, 1994
16. FERRER-MARTINEZ A, FELIPE A, NICHOLSON B, CASADO FJ, PASTOR-
ANGLADA M, MCGI VAN JD: Induction of high-affinity Na*dependent
glutamate transport by hypertonic stress in the renal epithelial cell line
NBL-1. Biochem J 3 10:689—692, 1995
17. FERRER-MARTINEZ A, CASADO FJ, FELIPE A, PASTOR-ANGLADA M:
Regulation of the Na,K-ATPase and the Na/K/Cl cotransporter in the
renal epithelial cell line NBL-1 under osmotic stress. Biochem J (in
press)
18. YORDY MR, BOWEN JW: Na,K-ATPase expression and cell volume
during hypertonic stress in human renal cells. Kidney mt 43:940—948,
1993
19. BHUTADA A, PEREZ C, CHON DC, ISMAIL-BEIGI F: Induction of
Na,K-ATPase activity and subunit mRNA abundance by serum in
a rat liver cell line. Am J Physiol 258:C1044—C1050, 1990
20. BRADFORD MM: A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 72:248—254, 1976
21. LONGO N, GRIFFIN LD, ELSAS U: A simple method for evaluation of
Rb transport and Na,K pump stoichiometry in adherent cells.
Am J Physiol 260:C1341—C1346, 1991
22. CHOMCZYNSKI P, SACCHI N: Single step method of RNA isolation by
acid guanidium thiocyanate-phenol-cloroform extraction. Anal Bio-
chem 162:156—159, 1987
23. FERRER-MARTINEZ A, FELIPE A, CASADO FJ, PASTOR-ANGLADA M:
Differential regulation of Na,KtATPase in the obese Zucker rat.
Am J Physiol (in press)
24. COLE E, SKORECKI K, CHEUNG F, WONG PY, FuNG LS, LEGY GA:
Cyclosporine A in contrast a cyclosporine metabolite (OL-17) specif-
ically inhibits growth of renal cells in culture. Transplant Proc 20:732—
737, 1988
25. BOWEN JW: Regulation of Na,K-ATPase expression in cultured renal
cells by incubation in hypertonic medium. Am J Physiol 262:C845—
C853, 1992
26. BERTORELLO A, KATZ AT: Short-term regulation of renal Na,Kt
ATPase activity: Physiological relevance and cellular mechanisms.
Am J Physiol 265:F743—F755, 1993
27. ACKERMANN U, GEERING K: Mutual dependence of Na,K-ATPase a-
and /3-subunits for correct post-translational processing and intracel-
lular transport. FEBS Lett 269:105—108, 1990
28. QIAN NX, PASTOR-ANGLADA M, ENGLESEERG E: Evidence for coor-
dinate regulation of the A system for amino acid transport and the
mRNA for the al subunit of the Na,K-ATPase gene in Chinese
hamster ovary cells. Proc NatI Acad Sci USA 88:3416—3420, 1991
29. PEREZ C, BHUTADA A, I5MAIL-BEIGI F: Induction of Na,K-ATPase
subunit mRNAs by cycloheximide in a rat liver cell line. Am J Physiol
260:C417—C423, 1991
30. BHUTADA A, WASSYNGER WW, I5MAIL-BEIGI F: Dexamethasone
markedly induces Na.K-ATPase mRNA1 in a rat liver cell line. J Biol
Chem 266:10859—10866, 1991
31. YARD BA, PANCHAM RR, PAAPE ME, DANA MR, VAN Es LA, VAN
DEN WOUDE, FJ: CsA, FK506, corticosteroids and rapamycin inhibit
TNFa production by cultured PTEC. Kidney mnt 44:352—358, 1993
32. IHARA H, HOSOKAWA S, OGIN0 T, ARIMA M, IKOMA F: Activation of
K channel and inhibition of Na,K -ATPase of human erythrocytes
by cyclosporine: Possible role in hyperpotassemia in kidney transplant
recipients. Transplant Proc 22:1736—1739, 1990
33. MORROW IS, CIANCI CD, ARDITO T, MANN AS, KASHIGARIAN M:
Ankyrin links fodrin to the alpha subunit of Na,K-ATPase in
Madin-Darby canine kidney cells and in intact renal tubule cells. J Cell
Biol 108:455—465, 1985
34. NELSON WJ, HAMMERION RW: A membrane cytoskeletal complex
containing Na*,K*ATPase, ankyrin, fodrin in Madin-Darhy canine
kidney (MDCK) cells: Implications for the biogenesis of epithelial cell
polarity. J Cell Biol 108:893—902, 1989
35. MouToRIs BA, DAHI, R, GEERDES A: (ytoskeleton disruption and
apical redistribution of proximal tubule Na,K'-ATPasc during isch-
emia. Am J Physiol 263:F488—F495, 1992
